MNTA: Your post reiterates the position for some here as to why MNTA probably has the upper hand with the FDA, (assuming anyone does.) MNTA's position of requiring sameness suggests MNTA has the ability to exactly replicate Lovenox, while Teva's position reveals possible weakness.
Market Data 
Markets 
AI
